Hdg: ICMR successfully tests first long-lasting male contraceptive
Hdg: ICMR successfully tests first long-lasting male contraceptive
The Indian Council of Medical Research (ICMR) has concluded a seven-year study on the male contraceptive RISUG, finding it to be safe and effective. RISUG is a non-hormonal injectable contraceptive that provides long-lasting sterility with complete reversibility. The study involved 303 healthy male volunteers and found that non-hormonal injectable male contraceptive RISUG (Reversible Inhibition of Sperm under Guidance) is safe and efficacious.
The Indian Council of Medical Research (ICMR) has concluded a seven-year study on the male contraceptive RISUG, finding it to be safe and effective. RISUG is a non-hormonal injectable contraceptive that provides long-lasting sterility with complete reversibility. The study involved 303 healthy male volunteers and found that non-hormonal injectable male contraceptive RISUG (Reversible Inhibition of Sperm under Guidance) is safe and efficacious.
We use cookies to improve your experience on our site and to show you relevant advertising. To find out more, read our updated privacy policy and cookie policy
Through RSS Feeds 
The Indian Council of Medical Research (ICMR) has concluded a seven-year study on the male contraceptive RISUG, finding it to be safe and effective. RISUG is a non-hormonal injectable contraceptive that provides long-lasting sterility with complete reversibility. The study involved 303 healthy male volunteers and found that non-hormonal injectable male contraceptive RISUG (Reversible Inhibition of Sperm under Guidance) is safe and efficacious. 
